- Occupational therapy
- Module 8
- Section 3 of 6
The Drug Regimen Review and What You Collaborate On
At a start of care the OT leads (a Medicare patient, OT plus PT or SLP, without skilled nursing), the comprehensive assessment includes a review of every medication the patient takes, and the OT completes it as the assessing clinician. The review looks for possible adverse effects, drug interactions, duplicate drugs and doses not taken as ordered.
One Clinician Completes It
The guidance manual has one clinician complete the drug regimen review, with collaboration allowed. The review starts from every bottle, inhaler, patch and tube of cream in the house, not only the discharge list, since the two can disagree. What else an OT may do with medications, such as setting up a weekly pill organizer, follows the state's OT practice act and the agency's written policy. A patient who needs ongoing teaching about medications may need nursing added, and that is the practitioner's order to give.
A Clinically Significant Issue
A dose that does not match the hospital's discharge list, a new drug that interacts with one the patient already takes, a new symptom that may be a side effect: each can be a clinically significant issue. When the review finds one, the OT contacts the physician or allowed practitioner, and that contact and the actions the practitioner recommends are completed by midnight of the next calendar day. For a finding at a Thursday visit, both are done by the end of Friday. The note records whom the OT reached, when, what was reported and what was done. The deadline is the latest the rule allows; a finding that cannot wait is reported at once, in the way the agency's written policy says.
What You Collaborate On
The comprehensive assessment also asks about skin, breathing and other areas an OT sees less often. Only the assessing clinician completes and signs it, but where the agency's written policy allows collaboration, clinicians may work together to collect data for any item, so the OT may gather skin and breathing findings with nursing staff. The answers remain the OT's to choose and sign.
The Assessment Date
The assessment's date is the last day the assessing clinician gathered information used to complete it. If the OT gathers the last of it on a second visit two days later, that second visit's date is the assessment date, and it still has to fall inside the comprehensive assessment's deadline.
Sources
- 42 CFR 484.55(c), Code of Federal Regulations
- OASIS-E2 Guidance Manual ch. 3, Drug Regimen Review, CMS
- OASIS-E2 Guidance Manual ch. 1 §1.5.8.1, CMS